The Sahlgrenska University Hospital is a hospital network associated with the Sahlgrenska Academy at the University of Gothenburg in Gothenburg, Sweden. With 17,000 employees the hospital is the largest hospital in Sweden by a considerable margin, and the second largest hospital in Europe.

There are 2,000 beds in Sahlgrens hospital, Department of Hematology.

During the past decade, Sahlgrens hospital, Department of Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sahlgrens hospital, Department of Hematology" are "PTLD" (1 trials), "Post-transplantation Lymphoproliferative Disorder" (1 trials) and "Posttransplant Lymphoproliferative Disorder" (1 trials). Many other conditions were trialed in "Sahlgrens hospital, Department of Hematology" in a lesser frequency.

Most popular intervention types in "Sahlgrens hospital, Department of Hematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CHOP" (1 trials), "Rituximab" (1 trials), "rituximab monotherapy" (1 trials) and "sequential R-CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sahlgrens hospital, Department of Hematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sahlgrens hospital, Department of Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sahlgrens hospital, Department of Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sahlgrens hospital, Department of Hematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".